Paper Details

  1. Home
  2. Paper Details

Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis.

Author: BestLawrence Mj, CooperNicola J, CowlinMaxine, DavidsonBrian R, FreemanSuzanne C, GurusamyKurinchi Selvan, LeungJeffrey, MilneElisabeth Jane, PavlovChavdar S, PayneAnna, SuttonAlex J, ThorburnDouglas, TsochatzisEmmanuel, WalshawDana, WilliamsNorman R

Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Liver transplantation is the best treatment for liver failure. After surgery, people need medication to prevent their body from rejecting the new liver. These medications are divided into those used in the first few months after surgery (induction immunosuppression) and those used long-term (maintenance immunosuppression). There's a lot of debate about whether the initial medications are necessary and which are best.
Paper Details　
Original Abstract of the Article :
Liver transplantation is considered the definitive treatment for people with liver failure. As part of post-liver transplantation management, immunosuppression (suppressing the host immunity) is given to prevent graft rejections. Immunosuppressive drugs can be classified into those that are used for...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984652/

データ提供：米国国立医学図書館（NLM）

Navigating the Immune System: Induction Immunosuppression After Liver Transplantation

Liver transplantation is a life-saving procedure, but the immune system's tendency to reject the new organ presents a significant challenge. This study explores the use of induction immunosuppression, a short-term therapy aimed at suppressing the immune system after liver transplantation. The researchers conducted a network meta-analysis to compare the effectiveness of different induction immunosuppressive agents. Their findings suggest that while induction immunosuppression is generally beneficial, the optimal choice of agent remains uncertain, highlighting the need for individualized patient care and careful consideration of various factors.

Induction Immunosuppression: A Complex Decision in Liver Transplantation

This study provides a comprehensive overview of induction immunosuppression in liver transplantation, highlighting the need for careful consideration of various factors when selecting the appropriate agent. The findings underscore the importance of individualizing treatment strategies based on patient characteristics, risk factors, and potential benefits and risks of different immunosuppressive agents.

Building a Bridge Between Patient and Graft: Immunosuppression in Liver Transplantation

Picture a camel crossing a bridge, navigating a precarious path to reach a new destination. After liver transplantation, the immune system can be like a treacherous bridge, threatening to reject the new organ. Induction immunosuppression, like a skilled bridge builder, helps suppress the immune system, allowing the patient's body to accept the new liver. This study helps clinicians navigate the complexities of immunosuppression, ensuring the best possible outcomes for liver transplant recipients.

Dr.Camel's Conclusion

This study delves into the intricate landscape of immunosuppression after liver transplantation. The choice of induction immunosuppressive agent, like navigating a desert landscape, requires careful consideration of various factors and the potential benefits and risks of different approaches. By understanding these complexities, we can work towards building stronger bridges between patients and their new organs, paving the way for successful transplantation and long-term health.

Date :
  1. Date Completed 2020-06-12
  2. Date Revised 2022-09-13
Further Info :

Pubmed ID

31978255

DOI: Digital Object Identifier

PMC6984652

Related Literature

Article Analysis
・Effective treatment of liver transplantation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.